Clinical trial

Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer

NCT06052098

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-10-11

PhaseNA

Study timeline

Study start (actual)2023-10-11Date precision: day

Registry last updated2023-12-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stage IA Lung Cancerunresolved

Interventions

The disposable pulmonary radiofrequency ablation catheter and pulmonary radiofrequency ablation systemDEVICE

The disposable percutaneous radiofrequency ablation needle and pulmonary radiofrequency ablation systemDEVICE

Sponsors & collaborators

Hangzhou Broncus Medical Co., Ltd.lead sponsor

Shanghai Chest Hospitalcollaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06052098 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.